A carregar...
Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma
Background: Precision therapy for lung cancer will require comprehensive genomic testing to identify actionable targets as well as ascertain disease prognosis. RNA-seq is a robust platform that meets these requirements, but microarray-derived prognostic signatures are not optimal for RNA-seq data. T...
Na minha lista:
| Publicado no: | J Natl Cancer Inst |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5051943/ https://ncbi.nlm.nih.gov/pubmed/27707839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djw200 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|